The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Despite extensive efforts, pancreatic cancer remains incurable. Most risk factors, such as genetic disposition, metabolic diseases or chronic pancreatitis cannot be influenced. By contrast, cigarette smoking, an important risk factor for pancreatic cancer, can be controlled. Despite the epidemiological evidence of the detrimental effects of cigarette smoking with regard to pancreatic cancer development and its unique property of being influenceable, our understanding of cigarette smoke-induced pancreatic carcinogenesis is limited. Current data on cigarette smoke-induced pancreatic carcinogenesis indicate multifactorial events that are triggered by nicotine, which is the major pharmacologically active constituent of tobacco smoke. In addition to nicotine, a vast number of carcinogens have the potential to reach the pancreatic gland, where they are metabolized, in some instances to even more toxic compounds. These metabolic events are not restricted to pancreatic ductal cells. Several studies show that acinar cells are also greatly affected. Furthermore, pancreatic cancer progenitor cells do not only derive from the ductal epithelial lineage, but also from acinar cells. This sheds new light on cigarette smoke-induced acinar cell damage. On this background, our objective is to outline a multifactorial model of tobacco smoke-induced pancreatic carcinogenesis.

[1]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[2]  H. Friess,et al.  Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus , 2009, Cancer biology & therapy.

[3]  H. Schuller,et al.  Nicotinic receptor‐associated modulation of stimulatory and inhibitory neurotransmitters in NNK‐induced adenocarcinoma of the lungs and pancreas , 2009, The Journal of pathology.

[4]  D. Whitcomb,et al.  Inflammation and pancreatic cancer: an evidence-based review. , 2009, Current opinion in pharmacology.

[5]  Manal M. Hassan,et al.  Antidiabetic therapies affect risk of pancreatic cancer. , 2009, Gastroenterology.

[6]  Michael R. O'Connell,et al.  Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. , 2009, Archives of internal medicine.

[7]  R. Soares,et al.  Nicotine: a pro-angiogenic factor. , 2009, Life sciences.

[8]  B. Lindgren,et al.  Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. , 2009, Chemical research in toxicology.

[9]  H. Plummer,et al.  Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. , 2009, Carcinogenesis.

[10]  G. Feldmann,et al.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice , 2008, Proceedings of the National Academy of Sciences.

[11]  F. Sundler,et al.  Long-Term Nicotine Exposure Causes Increased Concentrations of Trypsinogens and Amylase in Pancreatic Extracts in the Rat , 2008, Pancreas.

[12]  J. Neoptolemos,et al.  Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. , 2008, Gastroenterology.

[13]  P. Garg,et al.  Direct versus indirect action of cholecystokinin on human pancreatic acinar cells: is it time for a judgment after a century of trial? , 2008, Gastroenterology.

[14]  Taeseung Lee,et al.  Effect of nicotine on human umbilical vein endothelial cells (HUVECs) migration and angiogenesis. , 2008, Vascular pharmacology.

[15]  P. Chowdhury,et al.  A cell-based approach to study changes in the pancreas following nicotine exposure in an animal model of injury , 2008, Langenbeck's Archives of Surgery.

[16]  R. Dhir,et al.  Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. , 2007, Pulmonary pharmacology & therapeutics.

[17]  A. Tamakoshi,et al.  Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort , 2007, International journal of cancer.

[18]  K. Pinkerton,et al.  Receptor-mediated tobacco toxicity: alterations of the NF-kappaB expression and activity downstream of alpha7 nicotinic receptor in oral keratinocytes. , 2007, Life sciences.

[19]  S. Larsson,et al.  Body mass index and pancreatic cancer risk: A meta‐analysis of prospective studies , 2007, International journal of cancer.

[20]  Y. Dor,et al.  β cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo , 2007, Proceedings of the National Academy of Sciences.

[21]  M. Korc,et al.  The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia , 2007, Proceedings of the National Academy of Sciences.

[22]  M. Barbacid,et al.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.

[23]  J. Barkin,et al.  Statins Reduce the Risk of Pancreatic Cancer in Humans: A Case-Control Study of Half a Million Veterans , 2007, Pancreas.

[24]  A. Masamune,et al.  Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice , 2007, Cancer science.

[25]  C. Bose,et al.  Nicotine‐induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function , 2007, Cell proliferation.

[26]  Mariza de Andrade,et al.  The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[27]  V. Beral,et al.  Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis , 2007, British Journal of Cancer.

[28]  U. Nöthlings,et al.  Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study , 2007, Cancer Causes & Control.

[29]  H. Milnerowicz,et al.  Dysfunction of the Pancreas in Healthy Smoking Persons and Patients With Chronic Pancreatitis , 2007, Pancreas.

[30]  C. Heeschen,et al.  Endothelial progenitor cells participate in nicotine-mediated angiogenesis. , 2006, Journal of the American College of Cardiology.

[31]  P. Chowdhury,et al.  Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. , 2006, World journal of gastroenterology.

[32]  Tatjana Crnogorac-Jurcevic,et al.  Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism , 2006, PLoS medicine.

[33]  S. Batra,et al.  Cigarette Smoke-induced Differential Expression of the Genes Involved in Exocrine Function of the Rat Pancreas , 2006, Pancreas.

[34]  M. Edelweiss,et al.  Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. , 2006, Surgery.

[35]  T. Takahashi,et al.  NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. , 2006, International journal of cancer.

[36]  P. Maisonneuve,et al.  Impact of Smoking on Patients With Idiopathic Chronic Pancreatitis , 2006, Pancreas.

[37]  E. Holly,et al.  Diabetes Mellitus and Pancreatic Cancer in a Population-Based Case-Control Study in the San Francisco Bay Area, California , 2006, Cancer Epidemiology Biomarkers & Prevention.

[38]  S. Grando,et al.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells , 2006, Journal of Cancer Research and Clinical Oncology.

[39]  S. Jee,et al.  Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men , 2006, International journal of cancer.

[40]  Gary T. Smith,et al.  Detection of Overexpressed COX‐2 in Precancerous Lesions of Hamster Pancreas and Lungs by Molecular Imaging: Implications for Early Diagnosis and Prevention , 2006, ChemMedChem.

[41]  D. Bartsch,et al.  Familial pancreatic cancer syndromes. , 2006, Endocrinology and metabolism clinics of North America.

[42]  S. Mousa,et al.  Cellular and molecular mechanisms of nicotine's pro‐angiogenesis activity and its potential impact on cancer , 2006, Journal of cellular biochemistry.

[43]  J. Siemiatycki,et al.  Diabetes mellitus and cancer risk in a population‐based case–controlstudy among men from Montreal, Canada , 2006, International journal of cancer.

[44]  Yihao Tian,et al.  Nicotine prevents the apoptosis induced by menadione in human lung cancer cells. , 2006, Biochemical and biophysical research communications.

[45]  S. Grando,et al.  Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells , 2006, Cancer biology & therapy.

[46]  S. Rane,et al.  Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. , 2006, Cytokine & growth factor reviews.

[47]  H. Friess,et al.  Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)–DNA adducts in human pancreatic tissues , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[48]  S. Batra,et al.  Chronic Pancreatic Inflammation Induced by Environmental Tobacco Smoke Inhalation in Rats , 2006, The American Journal of Gastroenterology.

[49]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[50]  S. Rogers,et al.  Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells , 2005, The AAPS Journal.

[51]  S. Larsson,et al.  Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts , 2005, British Journal of Cancer.

[52]  C. Bose,et al.  Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[53]  J. Klenk,et al.  Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria , 2005, British Journal of Cancer.

[54]  Jinjin Guo,et al.  Persistent Nicotine Treatment Potentiates Amplification of the Dihydrofolate Reductase Gene in Rat Lung Epithelial Cells as a Consequence of Ras Activation* , 2005, Journal of Biological Chemistry.

[55]  M. Tsao,et al.  The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors , 2005, Journal of Cancer Research and Clinical Oncology.

[56]  Mariza de Andrade,et al.  Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.

[57]  P. Maisonneuve,et al.  Risk factors for pancreatic cancer , 2005, Journal of cellular biochemistry.

[58]  A. Tamakoshi,et al.  Overview of the Epidemiology of Pancreatic Cancer Focusing on the JACC Study , 2005, Journal of epidemiology.

[59]  A. Andrén-sandberg,et al.  Cigarette smoking accelerates progression of alcoholic chronic pancreatitis , 2005, Gut.

[60]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[61]  Jinjin Guo,et al.  Long-term Exposure to Nicotine, via Ras Pathway, Induces Cyclin D1 to Stimulate G1 Cell Cycle Transition* , 2005, Journal of Biological Chemistry.

[62]  M. Thun,et al.  Obesity, Recreational Physical Activity, and Risk of Pancreatic Cancer In a Large U.S. Cohort , 2005, Cancer Epidemiology Biomarkers & Prevention.

[63]  P. Pour,et al.  Diabetes mellitus: a risk factor for pancreatic cancer? , 2005, Langenbeck's Archives of Surgery.

[64]  Lijun Xu,et al.  Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induces Phosphorylation of μ- and m-Calpain in Association with Increased Secretion, Cell Migration, and Invasion* , 2004, Journal of Biological Chemistry.

[65]  R. Fisher,et al.  Bile-pancreatic juice exclusion increases cholinergic M3 and CCK-A receptor expression and interleukin-6 production in ligation-induced acute pancreatitis. , 2004, American journal of surgery.

[66]  W. Wu,et al.  The Modulating Role of Nuclear Factor-κB in the Action of α7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone , 2004, Journal of Pharmacology and Experimental Therapeutics.

[67]  Xingming Deng,et al.  Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Promotes Functional Cooperation of Bcl2 and c-Myc through Phosphorylation in Regulating Cell Survival and Proliferation* , 2004, Journal of Biological Chemistry.

[68]  C. Logsdon,et al.  New insights into neurohormonal regulation of pancreatic secretion. , 2004, Gastroenterology.

[69]  T. Adrian,et al.  On the role of the islets of Langerhans in pancreatic cancer. , 2004, Histology and histopathology.

[70]  S. Krivoshiev,et al.  The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. , 2004, Diabetes & metabolism.

[71]  Alison P. Klein,et al.  Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds , 2004, Cancer Research.

[72]  H. Friess,et al.  Origin and Development of the Precursor Lesions in Experimental Pancreatic Cancer in Rats , 2003, Laboratory Investigation.

[73]  P. Maisonneuve,et al.  Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. , 2003, Gastroenterology.

[74]  L. Stitt,et al.  Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  R. Paffenbarger,et al.  Physical activity, body weight, and pancreatic cancer mortality , 2003, British Journal of Cancer.

[76]  A. Ziegler,et al.  BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.

[77]  P. Ruszniewski,et al.  Risk of pancreatic adenocarcinoma in chronic pancreatitis , 2002, Gut.

[78]  X. Thomas,et al.  Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  K. Imaida,et al.  Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on carcinogenicity in the prostate, colon and pancreas. , 2002, Mutation research.

[80]  M. Miller,et al.  The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK , 2002, Journal of Cancer Research and Clinical Oncology.

[81]  J. Mason,et al.  Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes , 2002, Oncogene.

[82]  P. Rayford,et al.  Pathophysiological Effects of Nicotine on the Pancreas: An Update , 2002, Experimental biology and medicine.

[83]  S. Amin,et al.  Identification of tobacco-derived compounds in human pancreatic juice. , 2002, Chemical research in toxicology.

[84]  H. Plummer,et al.  Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells , 2001, Journal of Cancer Research and Clinical Oncology.

[85]  P. Möller,et al.  Differential Effects of Caspase-1/Interleukin-1β–Converting Enzyme on Acinar Cell Necrosis and Apoptosis in Severe Acute Experimental Pancreatitis , 2001, Laboratory Investigation.

[86]  S. Murin,et al.  Cigarette smoking and the risk of pulmonary metastasis from breast cancer. , 2001, Chest.

[87]  R Yancik,et al.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. , 2001, JAMA.

[88]  G. Berglund,et al.  Survival of women with breast cancer in relation to smoking. , 2000, The European journal of surgery = Acta chirurgica.

[89]  R. Young,et al.  Up‐Regulation of Epidermal Growth Factor‐Receptors (EGF‐R) by Nicotine in Cervical Cancer Cell Lines: This Effect May Be Mediated by EGF , 2000, American journal of reproductive immunology.

[90]  P. Thomas,et al.  Low levels of expression of cytochromes P-450 in normal and cancerous fetal pancreatic tissues of hamsters treated with NNK and/or ethanol. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[91]  A. Tamakoshi,et al.  Cigarette Smoking as a Risk Factor for Chronic Pancreatitis: A Case-Control Study in Japan , 2000, Pancreas.

[92]  P Maisonneuve,et al.  Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. , 2000, The Medical clinics of North America.

[93]  H. Plummer,et al.  The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. , 1999, Cancer research.

[94]  K. Lillemoe,et al.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer , 1999, British Journal of Cancer.

[95]  C. Bassi,et al.  Incidence of cancer in the course of chronic pancreatitis , 1999, American Journal of Gastroenterology.

[96]  R. E. Jimenez,et al.  Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. , 1999, The American journal of pathology.

[97]  S. Hecht,et al.  DNA adduct formation from tobacco-specific N-nitrosamines. , 1999, Mutation research.

[98]  H. Schuller,et al.  Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. , 1998, Biochemical pharmacology.

[99]  M. Talamonti,et al.  Atypical acinar cell foci in human pancreas , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[100]  C. Kolar,et al.  Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells. , 1997, Cancer letters.

[101]  D. Rattner,et al.  A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens. , 1997, Surgery.

[102]  E. Dimagno,et al.  Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. , 1997, Journal of the National Cancer Institute.

[103]  T. Imazawa,et al.  Promotional effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) on N-nitrosobis(2-oxopropyl)amine (BOP)-initiated carcinogenesis in hamsters. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[104]  G A Colditz,et al.  A prospective study of cigarette smoking and the risk of pancreatic cancer. , 1996, Archives of internal medicine.

[105]  Zhaoshen Li,et al.  Chronic Pancreatitis and Pancreatic Cancer , 1996, Gastrointestinal Tumors.

[106]  S. Hecht,et al.  Effects of phenethyl isothiocyanate on the tissue distribution of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites in F344 rats. , 1995, Cancer research.

[107]  A. Tangoku,et al.  Structural and functional changes of rat exocrine pancreas exposed to nicotine , 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.

[108]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.

[109]  C. Mettlin,et al.  Influence of smoking on the development of lung metastases from breast cancer , 1995, Cancer.

[110]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[111]  Kazutomo Inoue,et al.  Carbachol and Cholecystokinin Enhance Accumulation of Nicotine in Rat Pancreatic Acinar Cells , 1995, Pancreas.

[112]  M. Reddy,et al.  Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. , 1994, Carcinogenesis.

[113]  T. Imazawa,et al.  Effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on N-nitrosobis(2-oxopropyl)amine (BOP)-initiated carcinogenesis in hamsters. , 1994, Cancer letters.

[114]  J. Minna,et al.  Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[115]  S. Hecht,et al.  Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes. , 1994, Chemical research in toxicology.

[116]  R. Alaggio,et al.  Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat , 1994, Journal of surgical oncology.

[117]  V. Feron,et al.  Immunocytochemical identification of DNA adducts, O6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1994, Carcinogenesis.

[118]  M. Thun,et al.  Cigarette smoking and risk of fatal breast cancer. , 1994, American journal of epidemiology.

[119]  V. Mohan,et al.  Risk of Pancreatic Carcinoma in Tropical Calcifying Pancreatitis: An Epidemiologic Study , 1994, Pancreas.

[120]  J K McLaughlin,et al.  Pancreatitis and the risk of pancreatic cancer. , 1993, The New England journal of medicine.

[121]  E. Wynder,et al.  A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1993, Cancer research.

[122]  H. Schuller,et al.  Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1993, Cancer research.

[123]  G. Browman,et al.  Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. , 1993, The New England journal of medicine.

[124]  E. Richter,et al.  Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. , 1992, Carcinogenesis.

[125]  H. Tajiri,et al.  Morphology and Pathological Significance of Focal Acinar Cell Dysplasia of the Human Pancreas , 1992, Pancreas.

[126]  A. Andrén-sandberg,et al.  Comparative histopathological findings in the pancreas of cigarette smokers and non-smokers. , 1990, Cancer letters.

[127]  M. Volm,et al.  Relationship between chemoresistance of lung tumours and cigarette smoking. , 1990, British Journal of Cancer.

[128]  M. Dubick,et al.  Dynamic changes of pancreatic structure and function in rats treated chronically with nicotine. , 1990, Toxicology and applied pharmacology.

[129]  H. Schuller,et al.  The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. , 1990, Cancer research.

[130]  D. Kokkinakis,et al.  Carcinogenicity of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, N-nitrosobis(2-hydroxypropyl)amine and cis-N-nitroso-2,6-dimethylmorpholine administered continuously in the Syrian hamster, and the effect of dietary protein on N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine carcinogenesis. , 1989, Carcinogenesis.

[131]  S. Amin,et al.  Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate. , 1989, Cancer research.

[132]  S. Amin,et al.  Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. , 1988, Cancer research.

[133]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[134]  G. Williams,et al.  Atypical and neoplastic acinar cell lesions of the pancreas in an autopsy study of Japanese patients , 1988, Cancer.

[135]  R. Ammann,et al.  [Changes in the serum pancreas enzyme following i.v. stimulation with secretin in subjects with a normal pancreas]. , 1987, Swiss medical weekly.

[136]  M. Dubick,et al.  Raised serum concentrations of pancreatic enzymes in cigarette smokers. , 1987, Gut.

[137]  L. Garfinkel,et al.  Histologic changes in pancreas in relation to smoking and coffee-drinking habits , 1986, Digestive Diseases and Sciences.

[138]  E. Gold,et al.  Epidemiology of pancreatic cancer , 1984, World Journal of Surgery.

[139]  S. Matsuno,et al.  Effects of immunosuppressive acidic protein on DMBA-induced pancreatic cancer in rats. , 1984, The Tohoku journal of experimental medicine.

[140]  K. Satake,et al.  Experimental pancreatic carcinoma as a model of human pancreatic carcinoma. , 1984, Clinical oncology.

[141]  A. Andriulli,et al.  Serum immunoreactive cationic trypsinogen response to secretin in normal subjects. , 1983, The American journal of gastroenterology.

[142]  H. Reznik-Schüller,et al.  Contrasting carcinogenic effects of nitroso-2,6-dimethylmorpholine given by gavage to F344 rats and Syrian golden hamsters. , 1982, Cancer letters.

[143]  O. Black,et al.  Metabolism of a carcinogen (7,12-dimethylbenzanthracene) in the pancreas of the Long-Evans rat. , 1981, Research communications in chemical pathology and pharmacology.

[144]  M. Rao,et al.  Histogenesis of pseudo-ductular changes induced in the pancreas of guinea pigs treated with N-methyl-N-nitrosourea. , 1980, Carcinogenesis.

[145]  R. Makuch,et al.  Smoking abstinence and small cell lung cancer survival. An association. , 1980, JAMA.

[146]  D. Nagel,et al.  Carcinogenicity of N-nitrosomethyl(2-oxopropyl)amine in Syrian hamsters. , 1980, Cancer research.

[147]  K. Ohlsson,et al.  Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation. , 1980, The Journal of clinical investigation.

[148]  D. Longnecker,et al.  Multiple atypical acinar cell nodules of the pancreas. , 1980, Human pathology.

[149]  H. Shinozuka,et al.  Focal acinar cell dysplasia in human pancreas , 1980, Cancer.

[150]  S. Hecht,et al.  Tobacco-specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. , 1978, Journal of the National Cancer Institute.

[151]  P. D. Webster,et al.  Origin of tubular complexes developing during induction of pancreatic adenocarcinoma by 7,12-dimethylbenz(a)anthracene. , 1978, The American journal of pathology.

[152]  P. Pour,et al.  Improvement of pancreatic cancer model by modified treatment with N-nitroso-bis (2-oxopropyl) amine. , 1977, Cancer letters.

[153]  D. Nagel,et al.  Metabolism of the pancreatic carcinogens N-nitroso-bis(2-oxopropyl)amine and N-nitroso-bis(2-hydroxypropyl)amine in the Syrian hamster. , 1976, Journal of the National Cancer Institute.

[154]  R. J. Elkort,et al.  Early neoplasia of rabbit pancreatic ductal cells induced dimethylhydrazine. , 1975, Cancer Research.

[155]  M. Rao,et al.  Pancreatic adenocarcinoma in inbred guinea pigs induced by n-methyl-N-nitrosourea. , 1975, Cancer research.

[156]  E. D. Jacobson,et al.  Inhibition of pancreatic secretion in man by cigarette smoking , 1972, Gut.

[157]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[158]  M. Carless,et al.  Nicotine induces cell proliferation, invasion and epithelial‐mesenchymal transition in a variety of human cancer cell lines , 2009, International journal of cancer.

[159]  A. Basu,et al.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. , 2009, The Lancet. Oncology.

[160]  D. Jaffe In Vivo Lineage Tracing Defines the Role of Acinar-to-Ductal Transdifferentiation in Inflammatory Ductal Metaplasia , 2008 .

[161]  M. de Andrade,et al.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. , 2008, Gastroenterology.

[162]  R. Hruban,et al.  Tumorigenesis and Neoplastic Progression Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia , 2007 .

[163]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[164]  H. Milnerowicz,et al.  [Influence of tobacco smoking on lipase activity in patients with pancreatitis]. , 2005, Przeglad lekarski.

[165]  W. Wu,et al.  4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. , 2005, Cancer research.

[166]  H. Schuller,et al.  Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters , 2005, Journal of Cancer Research and Clinical Oncology.

[167]  E. Sandgren,et al.  Modeling pancreatic cancer in animals to address specific hypotheses. , 2005, Methods in molecular medicine.

[168]  J. Minna Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. , 2003, The Journal of clinical investigation.

[169]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[170]  H. Friess,et al.  DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. , 1998, Cancer research.

[171]  J. A. Love,et al.  Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation. , 1998, Inflammation.

[172]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.

[173]  S. Hecht,et al.  Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. , 1991, Critical reviews in toxicology.

[174]  R. Hosotani,et al.  Inhibition of CCK or carbachol-stimulated amylase release by nicotine. , 1989, Life sciences.

[175]  J. Saavedra,et al.  Carcinogenesis and nucleic acid alkylation by some oxygenated nitrosamines in rats and hamsters. , 1988, Chemico-biological interactions.

[176]  M. Dipp,et al.  Interdigestive gastrointestinal motility and secretion of gastric acid and pancreatic enzymes in young cigarette smokers. , 1984, Digestion.

[177]  K. Satake,et al.  Pancreatic cancer developing in Sprague-Dawley rats after local application of 7,12-dimethyl benzanthracene (DMBA). , 1975, Osaka city medical journal.